Connect Biopharma Holdings Limited logo

CNTBConnect Biopharma Holdings Limited

CNTB Stock Price, Valuation & Chart | Connect Biopharma Holdings Limited

Compare

CNTB Historical price chart

CNTB Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization173.78M
PE Ratio-4.52
EPS-0.61
Trading Volume2.59M
Today's High/Low2.86/2.37
Dividend Yield0.00
52 Week High/Low3.82/1.23
Shares Outstanding62.96M
CNTB Financial Statement
CNTB Analyst ratings
CNTB Analysis & performance metrics

CNTB Company profile

Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious…

CNTB Management team

Management
Srikanth Pendyala M.D.
Senior Vice President of Clinical Development(Consultant)
David L. Szekeres J.D.
President
Barry D. Quart Pharm.D.CEO
Chief Executive Officer & Director
Raul Collazo Ph.D.
Vice President & Global Head of Medical Affairs
Jeff Cohn J.D.
General Counsel & Corporate Secretary
Sean T. Ristine
Vice President of Human Resources
Lisa Peraza CPA
Vice President of Finance
Lei Sun Ph.D.
Vice President of Biologics & Head of CMC
Total 8 executives

CNTB Frequently asked questions

What is Connect Biopharma Holdings Limited (CNTB) Stock Price?

Current stock price of Connect Biopharma Holdings Limited (CNTB) stock is $2.760. The stock price is +16.95% higher in the session. The intraday range can be seen from this page. Volume of Connect Biopharma Holdings Limited (CNTB) stock is 2.59M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Connect Biopharma Holdings Limited (CNTB) stock price going up or down today?

The stock price of Connect Biopharma Holdings Limited (CNTB) can change with earnings, company news, and overall market sentiment. Connect Biopharma Holdings Limited operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Connect Biopharma Holdings Limited stock expensive at its current price?

Whether Connect Biopharma Holdings Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CNTB on this page is -4.52. EPS on this page is -0.61. Compare those figures with peers and growth expectations before deciding if the current Connect Biopharma Holdings Limited price is justified.

How has the stock price of Connect Biopharma Holdings Limited (CNTB) performed historically?

Historical performance for Connect Biopharma Holdings Limited (CNTB) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CNTB reacted to past earnings and market events.

Should I buy Connect Biopharma Holdings Limited (CNTB) stock, at this price?

Buying Connect Biopharma Holdings Limited (CNTB) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.